Ignite Creation Date:
2025-12-24 @ 6:55 PM
Ignite Modification Date:
2026-01-01 @ 8:37 AM
Study NCT ID:
NCT00961857
Status:
COMPLETED
Last Update Posted:
2019-11-13
First Post:
2009-08-18
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Demonstrate the Bioequivalence of Sitagliptin/Metformin Combination Tablets and Concomitant Administration of Sitagliptin and Metformin as Individual Tablets (0431A-048)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-12-01
Start Date Type:
ACTUAL
Primary Completion Date:
2005-12-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2006-01-01
Completion Date Type:
ACTUAL
First Submit Date:
2009-08-18
First Submit QC Date:
None
Study First Post Date:
2009-08-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-11-08
Last Update Post Date:
2019-11-13
Last Update Post Date Type:
ACTUAL